Dave Greenwald, Ph.D retweeted
We have formed a strategic partnership with Neutron Therapeutics, the industry leader in neutron delivery technology, with the goal of aligning our efforts to establish a #BNCT center in the U.S. Read more: avikobnct.com/press-release/… #radiationoncology #precisionmedicine
Dave Greenwald, Ph.D retweeted
#Genetherapy holds great promise for a spectrum of diseases, but delivery of these therapies remains a key challenge, Kevin Foust, SVP for preclinical and translational medicine at Jaguar Gene Therapy, told ScienceBoard.net at #ASGCT22 bit.ly/3wtaVIV #ASGCT2022
Dave Greenwald, Ph.D retweeted
Come see how we are conceptually upending protein evolution approaches by building a machine learning-driven atlas to efficiently identify AAV capsids with multiple desired traits (improved tropisms + manufacturability).
Talk abstract 1201
May 19, 11:45am
@ASGCTherapy #ASGCT22
Deerfield and Baylor College of Medicine enter into $130M collaboration to advance novel medicines businesswire.com/news/home/2…
Deerfield launches X-Seed Award to support Underrepresented Company Founders businesswire.com/news/home/2…
Dave Greenwald, Ph.D retweeted
Johns Hopkins spinout Neuraly launches with $36M funding round. It’s the second eye-catching funding round from a Hopkins-originated biotech company this summer. WindMIL Therapeutics posted a $32.5 million Series B round in June. technical.ly/baltimore/2018/…
Dave Greenwald, Ph.D retweeted
30 yrs of research at Johns Hopkins led to approval of pembrolizumab to treat all cancers with defects in mismatch repair genes
Dave Greenwald, Ph.D retweeted
Wilmer is among the first #ophthalmology centers in the U.S. to offer corneal cross-linking. bit.ly/2fhgR0t #WorldKeratoconusDay
Piers Park Sailing Ctr provides sailing for youth and persons with disabilities. Please consider donating today! tinyurl.com/jobjnah
Dave Greenwald, Ph.D retweeted
Vikas Goyal: #entrepreneur use leverage where you have it, but know that all VCs talk to each other.
Dave Greenwald, Ph.D retweeted
Today we remember our past. Tomorrow, we welcome our future, Redonda G. Miller, M.D. our 1st female #president #TBT
Dave Greenwald, Ph.D retweeted
MA friends. If you agree that the non-compete reform loophole needs to be removed, please retweet this! nitter.gq/epaley/status/74852811…
Dave Greenwald, Ph.D retweeted
Celebrating my dear friend, @pgoldberg14 for all of her accomplishments at @Mass_Tech
Honored to have helped bring this important collaboration to JHU: businesswire.com/news/home/2…
Dave Greenwald, Ph.D retweeted
SLP 16/17 applications now open! Apply to become a part of a global network of creative entrepreneurs! #SLP #startup dld.bz/eBe5R
Dave Greenwald, Ph.D retweeted
Don't miss President Daniels discussing social innovation in Baltimore w @WalterIsaacson at 6pm @whitehouse event bit.ly/24tGmL8
Dave Greenwald, Ph.D retweeted
Scoring system for FAEs (financial AEs) resulting from medical treatment. Interesting concept #asco16 nitter.gq/med__twi/status/739517…
Innovative Companies Get Their Best Ideas from Academic Research — Here’s How They Do It hbr.org/2016/04/innovative-c…























